General Motors (NYSE:GM) is temporarily halting production at its Silao, Mexico plant, affecting output of its top-selling Chevrolet Silverado and GMC Sierra pickup trucks. The plant was idle for the first two weeks of July and is scheduled for further shutdowns during the weeks of August 4 and 11, according to sources familiar with the matter. While GM confirmed the downtime, it declined to share specific dates.
The company stated the move is part of “standard operating processes” aimed at optimizing production. Still, the decision is noteworthy as the Silverado and Sierra are GM’s most profitable vehicles and dominate the U.S. pickup market. These models are also manufactured at facilities in Fort Wayne, Indiana; Flint, Michigan; and Ontario, Canada.
Although it is routine for automakers to pause production for maintenance or model updates—especially during the July Fourth holiday—extended downtime is unusual for high-demand truck lines that typically operate around the clock. GM sold 278,599 Silverados and 166,409 Sierras in the first half of 2025, marking year-over-year increases of 2% and 12%, respectively.
The production pause comes amid wider automotive industry disruptions linked to U.S. President Donald Trump’s trade policies. Tariffs on imported vehicles and auto parts, along with China’s retaliatory restrictions on rare-earth materials, have forced manufacturers to reconfigure supply chains and production schedules.
As GM navigates these geopolitical and operational headwinds, the temporary idling of a key plant highlights the delicate balance between maintaining supply and adapting to policy-driven challenges. With pickups generating major revenue for GM, Ford, and Stellantis (NYSE:STLA), any extended disruption could ripple through the broader North American auto market.


Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Bank of America's $72.5M Epstein Settlement: What You Need to Know 



